Advertisement

Extrakorporale Therapien bei Patienten mit Lebererkrankungen auf der Intensivstation

  • V. FuhrmannEmail author
  • T. Horvatits
  • A. Drolz
  • K. Rutter
Leitthema

Zusammenfassung

Akutes und akut-auf-chronisches Leberversagen geht häufig mit der Beeinträchtigung anderer Organsysteme einher. Dies hat eine erhöhte Morbidität und Mortalität zur Folge. Extrakorporale Therapien sind in diesen Patientenpopulationen häufig erforderlich. Die bei diesen Patienten angewandten extrakorporalen Therapien sind einerseits konventionelle Nierenersatzverfahren und andererseits Leberunterstützungsverfahren. Letztere werden in artifizielle und bioartifizielle Leberunterstützungsverfahren unterteilt. Dieses Manuskript beinhaltet eine Übersicht hinsichtlich der derzeitigen Praxis für extrakorporale Therapien bei kritisch kranken Patienten mit Lebererkrankungen.

Schlüsselwörter

Leber Leberversagen Kritische Erkrankung Extrakorporale Zirkulation Nierenersatzverfahren 

Extracorporeal therapy of patients with liver disease in the intensive care unit

Abstract

Acute and acute-on-chronic liver failure are often associated with development of organ failure. Its occurrence is associated with high morbidity and mortality. Extracorporeal replacement therapies are frequently necessary in these patient populations. Replacement therapies can be divided into renal replacement therapies and liver support therapies. These therapies consist of artificial liver support systems (i.e., MARS® system, Prometheus®), which are able to remove water-soluble and albumin-bound toxins, and of bioartifical liver support systems. This manuscript provides a review of current practice in the extracorporeal support of patients with liver diseases in the intensive care unit.

Keywords

Liver Liver failure Critical illness Extracorporeal circulation Renal replacement therapy 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt. T. Horvatits, A. Drolz·und K. Rutter geben an, dass kein Interessenkonflikt besteht. V. Fuhrmann erhielt Forschungsunterstützung von Baxter/Gambro und war für Baxter/Gambro als Referent tätig. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Horvatits T, Trauner M, Fuhrmann V (2013) Hypoxic liver injury and cholestasis in critically ill patients. Curr Opin Crit Care 19:128–132PubMedCrossRefGoogle Scholar
  2. 2.
    Fuhrmann V, Kneidinger N, Herkner H et al (2011) Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med 37:1302–1310PubMedCrossRefGoogle Scholar
  3. 3.
    O’Brien A, Welch C, Singer M et al (2012) Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients. Intensive Care Med 38:991–1000CrossRefGoogle Scholar
  4. 4.
    Bernal W, Auzinger G, Dhawan A et al (2010) Acute liver failure. Lancet 376:190–201PubMedCrossRefGoogle Scholar
  5. 5.
    Jäger B, Drolz A, Michl B et al (2012) Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis. Hepatology 56:2297–2304PubMedCrossRefGoogle Scholar
  6. 6.
    Fuhrmann V, Kneidinger N, Herkner H et al (2009) Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 35:1397–1405PubMedCrossRefGoogle Scholar
  7. 7.
    Lee M, Kim D, Kamath P et al (2011) Outcome of patients with cirrhosis requiring critical care in the United States. Hepatology 54:P483CrossRefGoogle Scholar
  8. 8.
    Moreau R, Jalan R, Gines P et al (2013) Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 144:1426–1437PubMedCrossRefGoogle Scholar
  9. 9.
    Wong F, Nadim MK, Kellum JA et al (2011) Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 60:702–709PubMedCrossRefGoogle Scholar
  10. 10.
    Wong F, O’Leary J, Reddy KR et al (2013) New consensus definintion of acute kidney injury predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology 145:1280–1288PubMedCrossRefGoogle Scholar
  11. 11.
    Martin-Llahi M, Guevara M, Torre A et al (2011) Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 140:488–496PubMedCrossRefGoogle Scholar
  12. 12.
    Cholongitas E, Senzolo M, Patch D et al (2009) Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality. Eur J Gastroenterol Hepatol 21:744–750PubMedCrossRefGoogle Scholar
  13. 13.
    Fraley D, Burr R, Bernardini J et al (1998) Impact of acute renal failure on mortality in patients with end-stage liver disease with or without transplantation. Kidney Int 54:518–524PubMedCrossRefGoogle Scholar
  14. 14.
    Trey C, Davidson CS (1970) The management of fulminant hepatic failure. Prog Liver Dis 3:282–298PubMedGoogle Scholar
  15. 15.
    Lee WM, Squires RH Jr, Nyberg SL et al (2008) Acute liver failure: summary of a workshop. Hepatology 47:1401–1415PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    O’Grady JG, Alexander GJ, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439–445Google Scholar
  17. 17.
    Krisper P, Haditsch P, Stauber R et al (2005) In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 43(3):451–457PubMedCrossRefGoogle Scholar
  18. 18.
    Stadlbauer V, Krisper P, Aigner R et al (2006) Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 10(6):R169PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Stadlbauer V, Krisper P, Beuers U et al (2007) Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure. ASAIO J 53:187–193PubMedCrossRefGoogle Scholar
  20. 20.
    Laleman W, Wilmer A, Evenepoel P et al (2006) Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 10(4):R108PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Faybik P, Hetz H, Mitterer G et al (2011) Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system. Crit Care Med 39:273–279PubMedCrossRefGoogle Scholar
  22. 22.
    Schultheiß C, Saugel B, Philip V et al (2012) Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care 16:R162PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Demetriou AA, Brown RS Jr, Busuttil RW et al (2004) Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 239:660–667PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Drolz A, Jager B, Wewalka M et al (2013) Clinical impact of arterial ammonia levels in ICU patients with different liver diseases. Intensive Care Med 39:1227–1237PubMedCrossRefGoogle Scholar
  25. 25.
    Drolz A, Saxa R, Scherzer T, Fuhrmann V (2011) Extracorporeal artificial liver support in hypoxic liver injury. Liver Int 31:19–23PubMedCrossRefGoogle Scholar
  26. 26.
    Brochard L, Abroug F, Brenner M et al (2010) An official ATS/ERS/ESICM/SCCM/SRLF Statement: prevention and management of acute renal failure in the ICU patient. Am J Respir Crit Care Med 181:1128–1155PubMedCrossRefGoogle Scholar
  27. 27.
    Hassanein TI, Tofteng F, Brown RS Jr et al (2007) Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46:1853–1862PubMedCrossRefGoogle Scholar
  28. 28.
    Kribben A, Gerken G, Haag S et al (2012) Effects of fractioned plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology 142:782–789PubMedCrossRefGoogle Scholar
  29. 29.
    Banares R, Nevens F, Larsen F et al (2013) Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology 57:1153–1162PubMedCrossRefGoogle Scholar
  30. 30.
    Saliba F, Camus C, Durand F et al (2013) Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure. Ann Intern Med 159:522–531PubMedCrossRefGoogle Scholar
  31. 31.
    Camus C, Lavoue S, Gacouin A et al (2009) Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy. Ther Apher Dial 13:549–555PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • V. Fuhrmann
    • 1
    Email author
  • T. Horvatits
    • 1
  • A. Drolz
    • 1
  • K. Rutter
    • 1
  1. 1.Klinik für IntensivmedizinUniversitätsklinikum Hamburg-EppendorfHamburgDeutschland

Personalised recommendations